ROLE OF RUNX1 REARRANGEMENTS IN TRIPLE-NEGATIVE BREAST CANCER PROGRESSION AND IMMUNE EVASION

$531,300FY2022Department of the ArmyDOD

Hmh Hospitals Corporation

Investigators

View source on USAspending →